Market assessment of tuberculosis diagnostics in Brazil in 2012

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Trajman, Anete ^a,b   Pinto, Marcia ^c   De Souza Jr, Ruy ^d   Freitas, Marianna ^d   Torrens, Ana ^d   Lima, Josué ^d   Barreira, Dráurio ^d   Perkins, Mark D ^e   Boehme, Catharina C ^e   Ginnard, Janet ^f   Jefferson, Carole ^g   Pantoja, Andrea ^h   Kik, Sandra V ^b,i   Chedore, Pamela ⁱ   Denkinger, Claudia M ^b,i   Pai, Madhukar ^b,i  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b MCGILL UNIVERSITY   (Canada)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d National Tuberculosis Program   (Brazil)

^e FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS   (Switzerland)

^f UNITAID   (Switzerland)

^g FIND   (United States)

^h McGill International TB Centre ^*

ⁱ MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC SENSITIVITY; ARTICLE; BRAZIL; DIAGNOSTIC TEST; HEALTH CARE COST; INTERFERON GAMMA RELEASE ASSAY; LIQUID CULTURE; MARKETING; NUCLEIC ACID AMPLIFICATION; SPUTUM SMEAR; TUBERCULIN TEST; TUBERCULOSIS;

EID: 84905457108     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104105     Document Type: Article

References (13)

1. World Health Organization (2013) Global Tuberculosis Report 2013: WHO report 2013. Geneva: WHO. 1-289 p.
2. Cobelens F, van den Hof S, Pai M, Squire SB, Ramsay A, et al. (2012) Which New Diagnostics for Tuberculosis, and When? J Infect Dis 205 (Suppl 2): S191-198.
3. World Health Organization (2013) Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system for the diagnosis of pulmonary and extrapulmonary TB in adults and children. Policy update (pre-publication copy). 1-89 p.
4. Pai NP, Vadnais C, Denkinger C, Engel N, Pai M (2012) Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries. PLoS Med 9: e1001306.
5. UNITAID (2013) Tuberculosis: Diagnostics Technology and Market Landscape. 1-43 p.
6. Pai M (2013) Diagnostics for tuberculosis: what test developers want to know. Expert Rev Mol Diagn 13: 311-314.
7. WHO/TDR/FIND (2006) Diagnostics for tuberculosis. Global demand and market potential. Geneva: World Health Organization. 1-203 p.
8. World Bank (2012) World Bank Data Official Exchange Rate.
9. Telles MA, Menezes A, Trajman A (2012) Bottlenecks and recommendations for the incorporation of new technologies in the tuberculosis laboratory network in Brazil. J Bras Pneumol 38: 766-770.
10. Ministério da Saúde (2010) Manual de Recomendaç ões para o Controle da Tuberculose no Brasil (Guidelines for the control of Tuberculosis in Brazil).
11. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL (2005) Methods for the Economic Evaluation of Health Care Programmes. New York, United States: Oxford University Press Inc. 1-379 p.
12. Brazilian Ministry of Health (2013) DATASUS. Sistema de Informação Ambulatorial (SIA/DATASUS). http://tabnet.datasus.gov. br/cgi/deftohtm.exe?sia/cnv/qbuf.def (last accessed on 23 August 2013).
13. World Health Organization (2012) Global Tuberculosis Control: WHO report 2012. Geneva: WHO. 1-272 p.